CNCE NASDAQ
Concert Pharmaceuticals, Inc.
1W: -0.1%
1M: -0.2%
3M: +73.7%
1Y: +171.8%
3Y: -12.0%
5Y: -60.2%
$8.37
Last traded 2023-03-03 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$165M
+3.8% ▲
5Y CAGR: +10.5%
Total Liabilities
$53M
+88.9% ▲
5Y CAGR: +29.1%
Shareholders Equity
$112M
-14.4% ▼
5Y CAGR: +5.6%
Cash & Investments
$143M
+8.5% ▲
5Y CAGR: +8.3%
Total Debt
$15M
-5.8% ▼
Net Debt
-$127M
-106.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $28M | $18M | $53M | $77M | $142M |
| Short-Term Investments | $176M | $143M | $59M | $55M | $1M |
| Cash & ST Investments | $203M | $161M | $112M | $132M | $143M |
| Net Receivables | $783K | $17M | $332K | $3M | $218K |
| Inventory | $0 | $0 | -$53M | -$53M | $0 |
| Other Current Assets | $2M | $3M | $58M | $60M | $7M |
| Total Current Assets | $206M | $180M | $117M | $143M | $150M |
| Property, Plant & Equip. | $2M | $9M | $17M | $15M | $14M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $4M | $3M | $4M | $1M | $1M |
| Total Non-Current Assets | $6M | $12M | $21M | $17M | $15M |
| Total Assets | $212M | $193M | $137M | $159M | $165M |
| — Liabilities — | |||||
| Accounts Payable | $658K | $1M | $881K | $230K | $3M |
| Short-Term Debt | $46K | $390K | $268K | $931K | $1M |
| Deferred Revenue | $1M | $1M | $8M | $3M | $8M |
| Other Current Liabilities | $4M | $6M | $8M | $6M | $5M |
| Total Current Liabilities | $6M | $9M | $17M | $10M | $16M |
| Long-Term Debt | $0 | $0 | $16M | $15M | $14M |
| Other Non-Current Liab. | $0 | $7M | $0 | $108K | $15M |
| Total Non-Current Liabilities | $9M | $16M | $19M | $18M | $37M |
| Total Liabilities | $15M | $25M | $36M | $28M | $53M |
| — Equity — | |||||
| Common Stock | $23K | $23K | $24K | $31K | $34K |
| Retained Earnings | -$76M | -$117M | -$195M | -$269M | -$349M |
| Accumulated OCI | -$407K | -$137K | -$31K | -$58K | -$76K |
| Total Stockholders Equity | $196M | $168M | $101M | $131M | $112M |
| Total Liabilities & Equity | $212M | $193M | $137M | $159M | $165M |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $16M | $16M | $15M |
| Net Debt | -$28M | -$18M | -$37M | -$61M | -$127M |
| Total Investments | $176M | $143M | $59M | $55M | $1M |